SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B

被引:5
作者
Arslan, Fatma Demet [1 ]
Karakoyun, Inanc [1 ]
Tatar, Bengu [2 ]
Pala, Emel Ebru [3 ]
Yildirim, Mustafa [4 ]
Ulasoglu, Celal [5 ]
Duman, Can [1 ]
Akar, Harun [4 ]
Kose, Sukran [2 ]
Basok, Banu Isbilen [1 ]
机构
[1] Univ Hlth Sci, Tepecik Training & Res Hosp, Dept Med Biochem, Izmir, Turkey
[2] Univ Hlth Sci, Tepecik Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Izmir, Turkey
[3] Univ Hlth Sci, Tepecik Training & Res Hosp, Dept Med Pathol, Izmir, Turkey
[4] Univ Hlth Sci, Tepecik Training & Res Hosp, Clin Internal Med, Izmir, Turkey
[5] Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Clin Gastroenterol, Istanbul, Turkey
关键词
Chronic Hepatitis B; Liver Fibrosis; Serum Marker; CHRONIC LIVER-DISEASES; STELLATE CELLS; TRANSIENT ELASTOGRAPHY; CLINICAL UTILITY; SERUM MARKERS; KINGS SCORE; BIOPSY; CIRRHOSIS; IDENTIFICATION; BIOCHEMISTRY;
D O I
10.5812/hepatmon.63310
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: This study aimed at creating a new predictive model of significant fibrosis in chronic hepatitis B using direct and indirect parameters and comparing this model with other noninvasive models for its validation in clinical settings. Methods: Patients (n = 81), according to the ISHAK score, were classified as mild and significant fibrosis. Serum matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-2, beta-nerve growth factor levels, and indirect parameters were analyzed. To evaluate the presence of significant hepatic fibrosis, well-known conventional models were also evaluated. The cut-off values of each model were determined using receiver operating characteristic curves to distinguish patients with mild and significant fibrosis. Results: Significant hepatic fibrosis index-1 was constructed using the following equation: (matrix metalloproteinase-2 x age x prothrombin time x direct bilirubin) / (albumin x platelet). The sensitivity and specificity for significant hepatic fibrosis index-1 were 73.3% and 95.6%, respectively. Area under the curve of significant hepatic fibrosis index-1 was 0.895 (P< 0.001), which was higher than the other models. Due to limitations of matrix metalloproteinase-2, significant hepatic fibrosis index-2 was constructed using a formula without matrix metalloproteinase-2. However, there were no significant differences between significant hepatic fibrosis index-1 and significant hepatic fibrosis index-2 or other models, except for 3 models. Conclusions: Significant hepatic fibrosis index-1 employs a new marker; matrix metalloproteinase-2 along with routine parameters had the best diagnostic performance for significant fibrosis in patients with chronic hepatitis B. Using significant hepatic fibrosis index-1 or even significant hepatic fibrosis index-2 might be an alternative approach in place of liver biopsy to predict significant fibrosis in chronic hepatitis B cohort.
引用
收藏
页数:9
相关论文
共 48 条
[1]   A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI) [J].
Ahmad, Waqar ;
Ijaz, Bushra ;
Javed, Fouzia T. ;
Gull, Sana ;
Kausar, Humaira ;
Sarwar, Muhammad T. ;
Asad, Sultan ;
Shahid, Imran ;
Sumrin, Aleena ;
Khaliq, Saba ;
Jahan, Shah ;
Pervaiz, Asim ;
Hassan, Sajida .
BMC GASTROENTEROLOGY, 2011, 11
[2]   Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation [J].
Asai, Keiko ;
Tamakawa, Susumu ;
Yamamoto, Masahiro ;
Yoshie, Masumi ;
Tokusashi, Yoshihiko ;
Yaginuma, Yuji ;
Kasai, Shinichi ;
Ogawa, Katsuhiro .
LIVER INTERNATIONAL, 2006, 26 (05) :595-603
[3]   Non-Invasive markers for hepatic fibrosis [J].
Baranova, Ancha ;
Lal, Priyanka ;
Birerdinc, Aybike ;
Younossi, Zobair M. .
BMC GASTROENTEROLOGY, 2011, 11
[4]   Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection [J].
Bruno, Raffaele ;
Sacchi, Paolo ;
Cima, Serena ;
Maiocchi, Laura ;
Patruno, Savino F. A. ;
Klersy, Catherine ;
Barbarini, Giorgio ;
Zuccaro, Valentina ;
Camma, Calogero ;
Filice, Gaetano .
DIGESTIVE AND LIVER DISEASE, 2011, 43 (07) :575-578
[5]   RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis B [J].
Chen, Baode ;
Ye, Bo ;
Zhang, Jian ;
Ying, Lixiong ;
Chen, Yu .
PLOS ONE, 2013, 8 (07)
[6]  
Coskun BD, 2015, REV ESP ENFERM DIG, V107, P740
[7]   Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection [J].
Cross, T. J. S. ;
Calvaruso, V. ;
Maimone, S. ;
Carey, I. ;
Chang, T. P. ;
Pleguezuelo, M. ;
Manousou, P. ;
Quaglia, A. ;
Grillo, F. ;
Dhillon, A. P. ;
Dusheiko, G. M. ;
Burroughs, A. K. ;
Harrison, P. M. .
JOURNAL OF VIRAL HEPATITIS, 2010, 17 (08) :546-554
[8]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845
[9]   AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients [J].
Eminler, Ahmet Tarik ;
Ayyildiz, Talat ;
Irak, Kader ;
Kiyici, Murat ;
Gurel, Selim ;
Dolar, Enver ;
Gulten, Macit ;
Nak, Selim G. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (12) :1361-1366
[10]   The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients [J].
Erdogan, Serpil ;
Dogan, Halef Okan ;
Sezer, Sevilay ;
Uysal, Sema ;
Ozhamam, Esra ;
Kayacetin, Serra ;
Koca, Yuksel .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (04) :300-308